Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

TheracosBio’s oral drug approved by FDA for adults with type 2 diabetes

January 24, 2023 Research and Development

TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of …
News

FDA grants Accelerated Approval for Seagen’s colorectal cancer treatment

January 23, 2023 Research and Development

Seagen Inc has been given FDA Accelerated Approval for its colorectal drug TUKYSA (tucatinib) after reviewing positive data from the …
News

AI and motion capture technology used to monitor movement disorders

January 23, 2023 Research and Development

A team of researchers have been developing a monitoring system to assess the progression of movement disorders. The new technology …
News

FDA rejects accelerated approval for Eli Lilly’s Alzheimer’s drug, donanemab

January 20, 2023 Research and Development

Eli Lilly has announced that its accelerated approval bid for Alzheimer’s disease drug, donanemab, has been rejected by the FDA. …
News

Genentech announce positive results from phase 3 IMbrave050 study

January 19, 2023 Research and Development

Genentech, based in California, US, has announced positive results from its phase 3 IMbrave050 trial, after the study met its …
News

Moderna’s mRNA vaccine appears promising for older adults with RSV

January 19, 2023 Research and Development

Moderna’s respiratory syncytial virus (RSV) vaccine has demonstrated positive levels of efficacy in older adults throughout a phase 3 trial. …
News

Neuronetics Inc. announces efficacy of treatment for neurohealth disorders

January 18, 2023 Research and Development

US-based commercial-stage medical technology company Neuronetics Inc., which focuses on designing, developing and marketing products that improve the quality of …
News

Shockwave Medical acquires Neovasc for $100m

January 18, 2023 Research and Development

US-based cardiovascular medical device company Shockwave Medical has signed a deal to acquire specialty medical device company Neovasc for around …
News

Luye Pharma’s Rykindo® approved by FDA for treatment of schizophrenia and bipolar 1 disorder

January 16, 2023 Research and Development

International pharmaceutical company, Luye Pharma, has announced that Rykindo® has received FDA approval for the treatment of schizophrenia in adult …
News

AstraZeneca’s Tezspire gains CHMP approval for the treatment of severe asthma

January 16, 2023 Research and Development

AstraZeneca has announced that Tezspire (also known as tezepelumab) has received approval from the EMA’s Committee for Medicinal Products for …
News

First patient enrolled in Inari DEFIANCE trial for deep vein thrombosis

January 13, 2023 Research and Development

Inari Medical has announced that the first patient has been enrolled in the DEFIANCE trial. This trial will evaluate the …
News

MediciNova completes enrolment for phase 2 clinical trial of ibudilast to treat recurrent and newly diagnosed glioblastoma

January 13, 2023 Research and Development

Biopharmaceutical company MediciNova has announced that its phase 2 clinical trial to assess MN-166 (ibudilast) for the treatment of recurring …
News

Ajinomoto and Exelixis sign agreement to develop novel ADCs for cancer treatment

January 12, 2023 Research and Development

Ajinomoto Co., a Japanese biotech company providing biopharmaceuticals, has signed a license agreement with Exelixis Inc., an oncology-focused biotech company, …
News

Oramed shares disappointing top-line results from phase 3 trial for type 2 diabetes treatment

January 12, 2023 Research and Development

Clinical stage pharmaceutical company, Oramed Pharmaceuticals, has announced top-line results from its phase 3 randomised, double-blind, placebo-controlled, multicentre trial, which …
News

Alvotech’s golimumab biosimilar phase 1 trial begins

January 12, 2023 Research and Development

Alvotech has announced that it has begun a phase 1 study evaluating the safety, tolerability and pharmacokinetics of its golimumab …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026